Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2018-08-01 / Am J Cancer Res 2018;8(8):1514-1527Vaccine immunotherapy in lung cancer: Clinical experience and future directions
/in International Publications, NSCLC, SCLC /von 2015-05-16 / Pharmacol. Ther. 2015 Sep;153:1-9γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.
/in Dendritic Cells, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)Immunotherapy prospects in the treatment of lung cancer and mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45Immunotherapy in lung cancer
/in International Publications, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2013-04-16 / Cancer Immunol. Immunother. 2013 May;62(5):909-18INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
/in Dendritic Cells, International Publications, SCLC /von 2010-06-01 / Expert Opin Biol Ther 2010 Jun;10(6):983-91Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
/in Dendritic Cells, International Publications, SCLC /von 2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de